SCHULMAN IRB was selected as the national IRB for the Cancer MoonShot 2020 program. “We are honored to be a part of this momentous initiative,” said Michael Woods, president and CEO of Schulman IRB. “Schulman’s IRB members and staff are excited to partner with leaders in the oncology field in these landmark studies, and we...
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
